Venkatesan Jayaprakash
Associate Professor
Pharmaceutical Sciences and TechÂ
Birla Institute of Technology
India
Biography
Dr. Venkatesan Jayaprakash is affiliated to Pharmaceutical Sciences and Tech , Birla Institute of Technology. Dr. Venkatesan Jayaprakash is currently providing services as Associate Professor. Dr. Venkatesan Jayaprakash has published numerous publications in various national and international peer-reviewed journals and presented scientific papers across the world. Because of the active association with different societies and academies as well as the contributions, Dr. Venkatesan Jayaprakash is been recognized by the subject experts around the world. Dr. Venkatesan Jayaprakash contributions are appreciated by various reputed awards. Dr. Venkatesan Jayaprakash clinical and scientific research interests include Antitubercular, Monoamine oxidase inhibitors, HDAC inhibitors, RR inhibitors, CDK inhibitors & CYP inhibitors, Protease inhibitors (DenV & ChikV) , Fusion inhibitors (DenV).
Research Interest
Antitubercular, Monoamine oxidase inhibitors, HDAC inhibitors, RR inhibitors, CDK inhibitors & CYP inhibitors, Protease inhibitors (DenV & ChikV) , Fusion inhibitors (DenV)
Publications
-
Yasmin S, Jayaprakash V. Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present. European journal of medicinal chemistry. 2017 Jan 27;126:879-93.
-
Siddique MU, McCann GJ, Sonawane VR, Horley N, Gatchie L, Joshi P, Bharate SB, Jayaprakash V, Sinha BN, Chaudhuri B. Quinazoline derivatives as selective CYP1B1 inhibitors. European Journal of Medicinal Chemistry. 2017 Apr 21;130:320-7.
-
Graser-Loescher G, Schoenhuber A, Ciglenec C, Eberl S, Krupitza G, Mader RM, Jadav SS, Jayaprakash V, Fritzer-Szekeres M, Szekeres T, Saiko P. Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine. Food and Chemical Toxicology. 2017 Oct 1;108:53-62.
